CIZ1 aggravates gastric cancer progression via mediating FBXL19-AS1 and miR-339-3p.

Wan, Houmin; Wang, Lianzhen; Huo, Bin; Qiao, Zhongpeng; Zhang, Yingli

Wan, Houmin; Wang, Lianzhen; Huo, Bin; Qiao, Zhongpeng; Zhang, Yingli.

Afiliação

Wan H; Department of Gastrointestinal Surgery, The NO.4 Municipal Hospital Affiliated to Shandong First Medical University, Jinan, 250031, Shandong Province, China.
Wang L; Department of Gastrointestinal Surgery, The NO.4 Municipal Hospital Affiliated to Shandong First Medical University, Jinan, 250031, Shandong Province, China.
Huo B; Department of Gastrointestinal Surgery, The NO.4 Municipal Hospital Affiliated to Shandong First Medical University, Jinan, 250031, Shandong Province, China.
Qiao Z; Department of Gastrointestinal Surgery, The NO.4 Municipal Hospital Affiliated to Shandong First Medical University, Jinan, 250031, Shandong Province, China.
Zhang Y; Department of Obstetrics, The NO.4 Municipal Hospital Affiliated to Shandong First Medical University, Jinan, 250031, Shandong Province, China.

Heliyon ; 9(11): e21061, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37954363

Palavras-chave

CIZ1; FBXL19-AS1; Gastric cancer; miR-339-3p

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google